Beyond the existing FLIPI parameters, the FLIPI2 study explored the inclusion of β2-microglobulin (B2M), a protein associated with lymphocyte activity and a potential marker of tumor burden and cell turnover. The gene discussed is HLA-G; the disease is neoplasm.